References
Chakravorty SS, Rye DB. Narcolepsy in the older adult: epidemiology, diagnosis and management. Drugs Aging 2003; 20(5): 361–76
Mitler MM, Hayduk R. Benefits and risks of pharmacotherapy for narcolepsy. Drug Saf 2002; 25(11): 791–809
Ohayon M, Zulley J, Guilleminault C, et al. Prevalence and pathologic associations of sleep paralysis in the general population. Neurology 1999; 52: 1194–200
Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998; 50 Suppl. 1: S16–22
Moscovitch A, Partinen M, Guilleminault C. The positive diagnosis of narcolepsy and narcolepsy’s borderland. Neurology 1993; 43: 55–60
Wake up! Treatment for childhood narcolepsy can prevent the development of serious social or academic problems. Drugs Ther Perspect 2001; 17(6): 5–8
Hussain A, Qadiri M, Rees P, et al. An unusual cause of falls in an elderly patient. Int J Clin Pract 1999; 53(5): 399–400
Littner M, Johnson SF, McCall WV, et al. Practice parameters for the treatment of narcolepsy: an update for 2000. Standards of Practice Committee. Sleep 2001 Jun 15; 24(4): 451–66
Physicians’ desk reference. 58th ed. Montvale (NJ): Thomson PPR, 2004
British National Formulary. No. 47. London: The Pharmaceutical Press, 2004 Mar
Billiard M, Besset A, Montplaisir J, et al. Modafinil: a double-blind multicentric study. Sleep 1994; 17: S107–12
Broughton R, Fleming J, George C, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 1997; 49(2): 444–51
Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group. Ann Neurol 1998; 43: 88–97
Guilleminault C, Pelayo R. Narcolepsy in children: a practical guide to its diagnosis, treatment and follow-up. Paediatr Drugs 2000; 2(1): 1–9
Larrosa O, de la Llave Y, Bario S, et al. Stimulant and anticat-aplectic effects of reboxetine in patients with narcolepsy: a pilot study. Sleep 2001; 24: 282–5
Hublin C, Partinen M, Heinonen E, et al. Selegiline in the treatment of narcolepsy. Neurology 1994; 44: 2095–101
Mayer G, Meier K, Hephata K. Selegeline hydrochloride treatment in narcolepsy: a double-blind placebo-controlled study. Clin Neuropharmacol 1995; 18(4): 306–19
Rye D, Dihenia B, Bliwise D. Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion. Depress Anxiety 1998; 7: 92–5
Rights and permissions
About this article
Cite this article
The sleepiness and cataplexy associated with narcolepsy are generally controllable with treatment. Drugs Ther. Perspect 20, 15–18 (2004). https://doi.org/10.2165/00042310-200420070-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200420070-00005